[go: up one dir, main page]

UA86741C2 - Ambroxol for treating painful conditions in the mouth and pharyngeal cavity - Google Patents

Ambroxol for treating painful conditions in the mouth and pharyngeal cavity

Info

Publication number
UA86741C2
UA86741C2 UA20040907789A UA20040907789A UA86741C2 UA 86741 C2 UA86741 C2 UA 86741C2 UA 20040907789 A UA20040907789 A UA 20040907789A UA 20040907789 A UA20040907789 A UA 20040907789A UA 86741 C2 UA86741 C2 UA 86741C2
Authority
UA
Ukraine
Prior art keywords
ambroxol
mouth
painful conditions
pharyngeal cavity
treating painful
Prior art date
Application number
UA20040907789A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Анке Эсперестер
Уве Пшорн
Жан-Мишель Викс
Original Assignee
Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27740434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA86741(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг filed Critical Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг
Publication of UA86741C2 publication Critical patent/UA86741C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the use of ambroxol and the pharmacologically compatible salts thereof for producing a medicament used for treating painful conditions in the mouth and pharyngeal cavity.
UA20040907789A 2002-02-27 2003-02-25 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity UA86741C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208313A DE10208313A1 (en) 2002-02-27 2002-02-27 Ambroxol for the treatment of painful conditions in the mouth and throat

Publications (1)

Publication Number Publication Date
UA86741C2 true UA86741C2 (en) 2009-05-25

Family

ID=27740434

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040907789A UA86741C2 (en) 2002-02-27 2003-02-25 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity

Country Status (21)

Country Link
EP (1) EP1480626A1 (en)
JP (1) JP2005518435A (en)
KR (1) KR20040084944A (en)
CN (1) CN1638749A (en)
AR (1) AR038698A1 (en)
AU (1) AU2003210345B2 (en)
BR (1) BR0308038A (en)
CA (1) CA2477105A1 (en)
DE (1) DE10208313A1 (en)
EC (1) ECSP045242A (en)
IS (1) IS7417A (en)
MX (1) MXPA04008220A (en)
MY (1) MY144781A (en)
PE (1) PE20030830A1 (en)
PL (1) PL371584A1 (en)
RU (1) RU2311176C2 (en)
TW (1) TW200306804A (en)
UA (1) UA86741C2 (en)
UY (1) UY27679A1 (en)
WO (1) WO2003072094A1 (en)
ZA (1) ZA200405635B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (en) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of acute pain
JP2005120063A (en) * 2003-10-14 2005-05-12 Boehringer Ingelheim Pharma Gmbh & Co Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032462A1 (en) * 2003-12-16 2005-06-17 Advance Holdings Ltd METHOD TO PREPARE A CARAMEL CONTAINING AMBROXOLO AND THE CANDY SO OBTAINED
DE102004021992A1 (en) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topical preparation containing ambroxol
JP2007084471A (en) * 2005-09-21 2007-04-05 Sunstar Inc Composition for oral cavity and method of selecting product for oral cavity
EP2015761A4 (en) * 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd METHODS AND COMPOSITION FOR THE TREATMENT OF THROAT SORE
JP5765934B2 (en) * 2009-12-28 2015-08-19 サンスター株式会社 Oral composition
JP6171683B2 (en) * 2012-08-03 2017-08-02 大正製薬株式会社 Solid preparation
CN105769908B (en) * 2016-05-06 2019-03-01 湖北凤凰白云山药业有限公司 A kind of drug of preventing phlegm from forming and stopping coughing and preparation method thereof
EP3538083B1 (en) 2016-11-14 2024-07-10 NeuVision Development LLC Formulations for the treatment of ocular surface diseases and related methods
CN106727621A (en) * 2016-11-22 2017-05-31 郑州仁宏医药科技有限公司 A kind of Western medicine powder for treating toothache
JP6844394B2 (en) * 2017-04-14 2021-03-17 大正製薬株式会社 Solid composition
EP3415143A1 (en) 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (en) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Drug combination used to treat infectious respiratory diseases
EP0138020B1 (en) * 1983-09-17 1992-06-03 Dr. Karl Thomae GmbH Anti-adhesive prophylactica and medicines containing a secretolytically active benzylamine derivative
DE3445226A1 (en) * 1983-12-14 1985-08-01 Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim Pharmaceutical product for the treatment and prophylaxis of infections and of coughs and obstructive airway disorders
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
DE4415553A1 (en) * 1994-05-03 1995-11-09 Behringwerke Ag Use of deoxyspergualin to prepare medicament
CN1220598A (en) * 1996-05-02 1999-06-23 大正制药株式会社 Suspension of poorly water-soluble acidic drugs
DE19933148A1 (en) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Lozenge containing ambroxol
JP2001151677A (en) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd Pharyngeal composition
RU2169557C1 (en) * 1999-12-22 2001-06-27 Александр Афанасьевич Яремчук Ambroxol syrup for treatment of patients with bronchopulmonal diseases
DE20102817U1 (en) * 2000-02-23 2001-06-07 Bolder Arzneimittel GmbH, 50968 Köln Lozenges and chewing pills with cyclodextrin
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics

Also Published As

Publication number Publication date
BR0308038A (en) 2004-12-28
CN1638749A (en) 2005-07-13
IS7417A (en) 2004-08-19
RU2311176C2 (en) 2007-11-27
TW200306804A (en) 2003-12-01
CA2477105A1 (en) 2003-09-04
KR20040084944A (en) 2004-10-06
DE10208313A1 (en) 2003-09-11
MY144781A (en) 2011-11-15
EP1480626A1 (en) 2004-12-01
PE20030830A1 (en) 2003-10-31
ZA200405635B (en) 2005-05-31
AU2003210345B2 (en) 2009-01-29
MXPA04008220A (en) 2004-11-26
UY27679A1 (en) 2003-09-30
ECSP045242A (en) 2004-09-28
AU2003210345A1 (en) 2003-09-09
JP2005518435A (en) 2005-06-23
PL371584A1 (en) 2005-06-27
RU2004129284A (en) 2005-06-10
AR038698A1 (en) 2005-01-26
WO2003072094A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
EG25822A (en) Quinolinyl-pyrrolopyrazoles
DE60327089D1 (en) SYSTEMS FOR MOVING AND / OR BACKING UP TISSUES IN THE UPPER AIRWAYS
PL366430A1 (en) Sustained release formulations of oxymorphone
UA86741C2 (en) Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
GEP20063905B (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
MXPA05008406A (en) Phenylacetamides and their use as glucokinase modulators.
GEP20074047B (en) Pramipexole once-daily dosage form
MXPA04003666A (en) Use of flibanserin in the treatment of sexual disorders.
CY1114448T1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THESE IN WOMEN'S SEXUAL INTERFERENCE
UA90518C2 (en) Pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, comprising a narcotic active ingredient and amine
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
TWD116417S1 (en) Implant delivery tool
MXPA05011472A (en) The use of azetidinecarboxamide derivatives in therapy.
GB2431346B (en) A combination composition comprising paracetamol and ibuprofen
NZ507203A (en) Use of dexmedetomidine for ICU sedation
MX2007005581A (en) Improved dosing regimen of temozolomide for treating cancer based on the patient s mgmt level.
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
SE9902597D0 (en) New use
NZ514014A (en) Method of treating sleep apnoea
ATE501719T1 (en) METHODS AND COMPOSITIONS FOR SOOTHING ORAL AND NASAL MUCOMS
ATE382357T1 (en) ANALGESIC FOR NEWBORN AND FETES
MXPA01009032A (en) Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12-production.
MX2007004040A (en) Novel use of -sympathomimetics having a 2-imidazoline structure.
MX2008002021A (en) Methods and compositions for soothing oral and nasal tissues.
ATE403424T1 (en) USE OF ZINC GLUCONATE TO TREAT HYDRADENITIS SUPPURATIVA